GlassScriptPhysician profile
Heather Stein
NPI 1235857632
$3,956.60
in general payments reported to CMS, 2019-2025
18 companies · $1,237 in 2025
The $1,237 reported for 2025 was more than what 84% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $69.56 · 2023: $1,639 · 2024: $1,011 · 2025: $1,237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,887.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $813.76 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $696.79 | 2022-2025 | Spravato, Invega Sustenna |
| Corium, LLC | $519.23 | 2023-2025 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $342.56 | 2022-2025 | Caplyta |
| Axsome Therapeutics, INC. | $288.25 | 2023-2025 | Auvelity |
| Alkermes, INC. | $232.95 | 2023 | Aristada, Lybalvi, Aristada Initio |
| Supernus Pharmaceuticals, INC. | $225.44 | 2023-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $212.18 | 2023-2024 | Jornay Pm |
| Vanda Pharmaceuticals INC. | $148.64 | 2024-2025 | Fanapt, Hetlioz |
| Takeda Pharmaceuticals U.S.A., INC. | $143.31 | 2023-2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $78.93 | 2023-2024 | Rexulti |
| Almatica Pharma LLC | $73.95 | 2024-2025 | Loreev Xr |
| Tempus Ai, INC | $46.42 | 2024 | |
| Tris Pharma INC | $38.08 | 2023-2024 | Dyanavel Xr |
| Neurocrine Biosciences, INC. | $31.86 | 2024 | Ingrezza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $23.42 | 2024 | Adzenys Xr-Odt |
| Collegium Pharmaceutical, INC. | $22.01 | 2025 | Jornay Pm |
| Idorsia Pharmaceuticals US INC | $18.82 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.